http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0478416-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c275038cf36535d44a526cb28203c03d
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D251-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P33-02
filingDate 1991-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1994-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d2468b558a58ade86749e0918af5d48b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_61244674fbd634e1a8342feb6580b7b7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c1081379d9430612709ac3ad8ea2ddc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f339e48de51a8274de50015cfacc036
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb92f5f933b8219a7b9c3425b8cfd143
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19949fd3ed6326cc004add4cc8d0df1d
publicationDate 1994-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0478416-B1
titleOfInvention Use of triazine- and pyrimidine derivatives for the preparation of medicaments reversing the resistance to anticancer and antimalarial agents
abstract Use, for obtaining medications reversing the resistance to anticancer and antimalarial agents, of compounds of formula I: n<IMAGE>n in which n n  - A denotes a -CH- group or a nitrogen atom, n  - and B, R1, R2 and R3 are as defined in the description, and their physiologically tolerable acid addition salts.
priorityDate 1990-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135979775
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3071359
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57123750
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID234775034
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136197710
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID56631372
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID234775301
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67833595
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID234775292
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13271717
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2520
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5770
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14184
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13258825
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129233874
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID56639505
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID234775793
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412677
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394880
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID643985
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7541
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67832793
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID234775496
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87057741
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID234778378
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2719
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412678
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID234778365
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395003
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226403877
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399992
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID234778390
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398325
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13271707
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID234778456
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23830
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13271706
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID234778411
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406888
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67833586

Total number of triples: 69.